Industrial air pollution linked to higher mortality in lung disease patients

Patients with fibrotic interstitial lung disease face accelerated mortality from industrial air pollution exposure, with disproportionate impact on communities of color.

In the industrial regions of North America, a quiet and invisible harm has been accumulating in the lungs of the vulnerable. A landmark study from the University of Pittsburgh, published in JAMA Internal Medicine, has traced the chemical fingerprints of factory and vehicle emissions to accelerated death in patients already living with fibrotic lung disease — finding not merely correlation, but a pattern of preventable loss. What makes this reckoning especially grave is its second revelation: that the burden of this industrial air does not fall equally, but settles most heavily upon communities

Industrial air pollution linked to higher mortality in lung disease patients

Cobertura Relacionada

Recibe The Register en tu bandeja